Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target

Abstract : Over the years, substantial evidence has definitively confirmed the existence of cancer stem-like cells within tumors such as Glioblastoma (GBM). The importance of Glioblastoma stem-like cells (GSCs) in tumor progression and relapse clearly highlights that cancer eradication requires killing of GSCs that are intrinsically resistant to conventional therapies as well as eradication of the non-GSCs cells since GSCs emergence relies on a dynamic process. The past decade of research highlights that metabolism is a significant player in tumor progression and actually might orchestrate it. The growing interest in cancer metabolism reprogrammation can lead to innovative approaches exploiting metabolic vulnerabilities of cancer cells. These approaches are challenging since they require overcoming the compensatory and adaptive responses of GSCs. In this review, we will summarize the current knowledge on GSCs with a particular focus on their metabolic complexity. We will also discuss potential approaches targeting GSCs metabolism to potentially improve clinical care.
Document type :
Journal articles
Complete list of metadatas

Cited literature [178 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02240417
Contributor : Elizabeth Bernardo <>
Submitted on : Thursday, August 1, 2019 - 4:03:06 PM
Last modification on : Sunday, August 4, 2019 - 1:09:53 AM

File

Pecqueur2019Eq14.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Delphine Garnier, Ophélie Renoult, Marie-Clotilde Alves-Guerra, François Paris, Claire Pecqueur. Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target. Frontiers in Oncology, Frontiers, 2019, 9, pp.118. ⟨10.3389/fonc.2019.00118⟩. ⟨inserm-02240417⟩

Share

Metrics

Record views

58

Files downloads

83